SAS and Carolina partner to accelerate antiviral drug development

Posted Nov 19, 2021
SAS, a leader in analytics and software services, and the University of North Carolina are teaming up to transform the drug development process to prevent infectious disease threats from turning into a pandemic like COVID-19. The partnership is focused on the work of the University’s Rapidly Emerging Antiviral Drug Development Initiative (READDI). (UNC.edu)

Related: Campus Connections

UNC and Duke ROTC To Ruck Men's Basketball Game Ball To Durham Friday
Members of the Army Reserve Officers' Training Corps (ROTC) from UNC and Duke will ceremonially tip off the season-ending matchup between the schools' men's basketball...
Thu Mar 5, 2026

“Every life is worth saving”: How a UNC researcher’s website is connecting communities to naloxone
Delesha Carpenter began her career as a researcher focused on pediatrics. About seven years ago, her path took an unexpected turn following the deaths of...
Wed Mar 4, 2026

Meet Sutton's Drug Store owner Don Pinney
Opened in 1923 by Lynwood and Lucy Sutton, Sutton's Drug Store was sold to Elliott Brummitt in 1965 with the understanding that the store wouldn’t...
Fri Feb 27, 2026

Carolina Covenant Documentary Wins Emmy
Chase Martin, assistant director of video for university development, and Jeyhoun Allebaugh, assistant director of photo and video for university development, accepted the best educational...
Wed Feb 25, 2026